<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/22/8607" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/22/8607/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/22/8607/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_8607"><akn:num>8607</akn:num><akn:heading>Other matters of cooperation</akn:heading><akn:content><akn:p>§ 8607. Other matters of cooperation(a) In generalActivities authorized under this section shall be carried out with the concurrence of the Secretary of State and aligned with the National Security Strategy of the United States, the United States Government Global Health Security Strategy, the Department of State Integrated Country Strategies, the USAID Country Development Cooperation Strategies, and any equivalent or successor plans or strategies, as necessary and appropriate.


(b) Development of health technologies(1) In generalThere is authorized to be appropriated to the Secretary of Health and Human Services $4,000,000 for fiscal years 2021 through 2023 for a bilateral cooperative program with the Government of Israel that awards grants for the development of health technologies, which may include health technologies listed in paragraph (2), subject to paragraph (3), with an emphasis on collaboratively advancing the use of technology and personalized medicine in relation to COVID–19.


(2) Types of health technologiesThe health technologies described in this paragraph are technologies such as, drugs and vaccines, ventilators, diagnostic tests, and technologies to facilitate telemedicine.


(3) Restrictions on fundingAmounts appropriated pursuant to paragraph (1) are subject to a matching contribution from the Government of Israel.


(4) Option for establishing new programAmounts appropriated pursuant to paragraph (1) may be expended for a bilateral program with the Government of Israel that—(A) is in existence on the day before January 1, 2021, for the purposes described in paragraph (1); or

(B) is established after January 1, 2021, by the Secretary of Health and Human Services, in consultation with the Secretary of State, in accordance with the Agreement between the Government of the United States of America and the Government of the State of Israel on Cooperation in Science and Technology for Homeland Security Matters, done at Jerusalem May 29, 2008 (or a s</akn:p></akn:content><akn:subsection eId="subsec_8607_a"><akn:num>(a)</akn:num><akn:heading>In general</akn:heading><akn:content><akn:p>(a) In general Activities authorized under this section shall be carried out with the concurrence of the Secretary of State and aligned with the National Security Strategy of the United States, the United States Government Global Health Security Strategy, the Department of State Integrated Country Strategies, the USAID Country Development Cooperation Strategies, and any equivalent or successor plans or strategies, as necessary and appropriate.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_8607_b"><akn:num>(b)</akn:num><akn:heading>Development of health technologies</akn:heading><akn:content><akn:p>(b) Development of health technologies</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_8607_c"><akn:num>(c)</akn:num><akn:heading>Coordinator of United States-Israel Research and Development</akn:heading><akn:content><akn:p>(c) Coordinator of United States-Israel Research and Development</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_8607_d"><akn:num>(d)</akn:num><akn:heading>Office of Global Policy and Strategy of the Food and Drug Administration</akn:heading><akn:content><akn:p>(d) Office of Global Policy and Strategy of the Food and Drug Administration</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_8607_e"><akn:num>(e)</akn:num><akn:heading>United States-Israel Energy Center</akn:heading><akn:content><akn:p>(e) United States-Israel Energy Center There is authorized to be appropriated to the Secretary of Energy $4,000,000 for fiscal year 2021 to carry out the activities of the United States-Israel Energy Center established pursuant to section 17337(d) of title 42.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_8607_f"><akn:num>(f)</akn:num><akn:heading>United States-Israel Binational Industrial Research and Development Foundation</akn:heading><akn:content><akn:p>(f) United States-Israel Binational Industrial Research and Development Foundation It is the sense of Congress that grants to promote covered energy projects conducted by, or in conjunction with, the United States-Israel Binational Industrial Research and Development Foundation should be funded at not less than $2,000,000 annually under section 17337(b) of title 42.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_8607_g"><akn:num>(g)</akn:num><akn:heading>Omitted</akn:heading><akn:content><akn:p>(g) Omitted</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_8607_h"><akn:num>(h)</akn:num><akn:heading>Annual policy dialogue</akn:heading><akn:content><akn:p>(h) Annual policy dialogue It is the sense of Congress that the Department of Transportation and Israel’s Ministry of Transportation should engage in an annual policy dialogue to implement the 2016 Memorandum of Cooperation signed by the Secretary of Transportation and the Israeli Minister of Transportation.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_8607_i"><akn:num>(i)</akn:num><akn:heading>Cooperation on space exploration and science initiatives</akn:heading><akn:content><akn:p>(i) Cooperation on space exploration and science initiatives The Administrator of the National Aeronautics and Space Administration shall continue to work with the Israel Space Agency to identify and cooperatively pursue peaceful space exploration and science initiatives in areas of mutual interest, taking all appropriate measures to protect sensitive information, intellectual property, trade secrets, and economic interests of the United States.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_8607_j"><akn:num>(j)</akn:num><akn:heading>Research and development cooperation relating to desalination technology</akn:heading><akn:content><akn:p>(j) Research and development cooperation relating to desalination technology Not later than one year after January 1, 2021, the Director of the Office of Science and Technology Policy shall submit a report that describes research and development cooperation with international partners, such as the State of Israel, in the area of desalination technology in accordance with section 9(b)(3) of the Water Desalination Act of 1996 (42 U.S.C. 10301 note) to—</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>